Oculocutaneous rosacea: a retrospective study in a pediatric hospital

Authors

  • María Florencia Martínez National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina
  • María Celeste Di Matteo National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina
  • Paola Cecilia Stefano National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina
  • María Marta Buján National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina
  • Eliana Cella National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina
  • Marcela Sandra Bocian National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina
  • Andrea Bettina Cervini National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v29i3.2441

Keywords:

rosacea, ocular rosacea, children

Abstract

Background: cutaneous rosacea (CR) is a chronic inflammatory skin condition, that occurs more frequently in adults. Prevalence in children is unknown. This entity presents erythema, flushing, telangiectasias, papules, pustules, glandular hypertrophy and/or fibrosis. There may be ocular affection, before, concomitant or after skin involvement. Ocular involvement may be the unique manifestation. Treatment is based on skin care, avoiding triggers, and topical and/or systemic treatment with anti-inflammatory activity.

Objectives: the aim of this study is to describe the cutaneous and ocular manifestations and treatment of the patients with a diagnosis of oculocutaneous rosacea (OCR).

Design: retrospective, descriptive and cross-sectional study.

Methods: medical records of patients with a diagnosis of ROC evaluated in our hospital from January 2011 to March 2017 were reviewed.

Results: we evaluated 25 patients with a diagnosis of OCR with an age between 1 to 19 years. Predominance of the papulo-pustular subtype was observed, two patients had the fimatous subtype and one of these presented as granulomatous variant, very rare in children. Ocular involvement was present in over 52% of the patients being, blepharitis the most frequent condition. Therapeutic approach Treatment options were according to the severity of the skin and ocular involvement.

Conclusions: ocular involvement in patients with a diagnosis of CR is frequent. We emphasized the importance of suspecting ocular rosacea in all patients with a diagnosis of CR associated with recurrent episodes of blepharitis and chalazion. The ophthalmological evaluation should be indicated in all patients with a diagnosis of CR regardless of the degree of skin involvement.

Author Biographies

María Florencia Martínez, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Former Resident Instructor, Dermatology Service

María Celeste Di Matteo, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Former Chief Resident, Dermatology Service

Paola Cecilia Stefano, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Staff Physician, Dermatology Service

María Marta Buján, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Staff Physician, Dermatology Service

Eliana Cella, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Staff Physician, Dermatology Service

Marcela Sandra Bocian, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Clinical Head, Dermatology Service

Andrea Bettina Cervini, National Pediatric Hospital “Prof. Dr. Juan P. Garrahan”, Autonomous City of Buenos Aires, Argentina

Head of the Dermatology Service

References

I. Kellen R, Silverberg NB. Pediatric rosacea. Cutis. 2016;98:49-53.

II. Bernal LE, Zarco AP, Campos P, Arenas R. Rosácea infantil. Bol Med Hosp Infant Mex. 2019;76:95-99.

III. Rodríguez-Acar M, Martínez-Muñoz JA. Rosácea infantil. Rev Cent Dermatol Pascua. 2011;20:18-21.

IV. Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, et ál. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008;144:167-171.

V. Drolet B, Paller AS. Childhood rosacea. Pediatr Dermatol. 1992;9:22-26.

VI. Ooi XT, Tan KB, Chandran N. A case of pediatric rosacea-skin and ocular involvement. Clin Case Rep. 2019;7:2414-2416.

VII. Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167:598-605.

VIII. Miguel AIM, Salgado MB, Lisboa MS, Henriques F, et ál. Pediatric ocular rosacea: 2 cases. Eur J Ophthalmol. 2012;4:664-666.

IX. Troielli P, González-Otero FM, Ríos Yuil JM, Vázquez-Martínez OT, et ál. Actualización y recomendaciones para el diagnóstico y tratamiento de la rosácea. Med Cutan Ibero Lat Am. 2016;44:7-26.

X. Kaminsky A, Flórez-White M, Piquero-Martín J, Herane MI, et ál. Informe del consenso Ibero-Latinoamericano 2016 sobre la clasificación clínica y terapéutica de la rosácea. Med Cutan Iber Lat Am. 2016;44:6-10.

XI. Keshtcar-Jafari A, Akhyani M, Ehsani AH, Ghiasi M, et ál. Correlation of the severity cutaneous rosacea with ocular rosacea. Indian J Dermatol Venereol Leprol. 2009;75: 405-406.

XII. Potz-Biedermann C, Mehra T, Deuter C, Zierhut M, et ál. Ophthalmic rosacea: case report in a child and treatment recommendations. Pediatr Dermatol. 2015;32:522-525.

XIII. Di Matteo MC, Stefano PC, Cirio A, López B, et ál. Rosácea oculocutánea en un niño. Arch Argent Pediatr. 2019;117:170-172.

XIV. Mássimo I, Andrada R, Hernández H, Mássimo JA. Rosácea en la infancia. Rev Hosp Niños B Aires. 2008;50:188-192.

XV. Martínez MF, Piegari Feliú MA, Di Matteo MC, Tellería RL, et ál. Microbiota: un ecosistema inteligente. Dermatol Argent. 2022;28:143-149.

XVI. Soto AC, Villani ME, Sánchez G, Merola G. Rosácea granulomatosa en la infancia. Dermatol Argent. 2019;25:84-86.

XVII. Boralevi, F, Léauté-Labrèze C, Lepreux S, Barbarot S, et ál. Idiopathic facial aseptic granuloma: a multicentre prospective study of 30 cases. Br J Dermatol. 2007;156:705-708.

XVIII. Docampo-Simón A, Sánchez-Pujol MJ, Schneller-Pavelescu L, Berbegal L, et ál. Granuloma aséptico facial idiopático: características clinicopatológicas y ecográficas. An Pediatr (Barc). 2020;92:297-299.

XIX. Garais JA, Bonetto VN, Frontino L, Salduna MD, et ál. Granuloma aséptico facial idiopático. A propósito de un caso. Arch Argent Pediatr. 2019;117:56-58.

Published

2023-12-01

Issue

Section

Original Articles